香雪制药(300147) - 2023 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2023 was ¥588,724,855.57, a decrease of 4.07% compared to ¥613,719,586.39 in the same period last year[3] - Net profit attributable to shareholders was ¥4,536,891.13, representing a significant increase of 108.34% from a loss of ¥54,380,193.73 in the previous year[3] - The net cash flow from operating activities improved to ¥54,977,540.05, a remarkable increase of 467.27% compared to a negative cash flow of ¥14,969,306.51 in the same period last year[3] - Basic earnings per share rose to ¥0.01, up 112.50% from a loss of ¥0.08 per share in the previous year[3] - Total operating revenue for Q1 2023 was CNY 588,724,855.57, a decrease of 4.8% compared to CNY 613,719,586.39 in the same period last year[18] - The company reported a net loss of CNY 495,579,610.22, slightly improved from a loss of CNY 500,116,501.35 in the previous year[16] - The net profit for Q1 2023 was ¥8,281,817.19, a significant recovery from a net loss of ¥41,900,248.37 in the same period last year, marking a turnaround of over 119%[19] - Operating profit reached ¥15,158,572.24, compared to an operating loss of ¥41,298,471.93 in Q1 2022, indicating a strong operational improvement[19] - The company reported a total comprehensive income of ¥3,899,115.34, recovering from a comprehensive loss of ¥42,054,654.04 in the same quarter last year[20] - Basic and diluted earnings per share were both ¥0.01, compared to a loss per share of ¥0.08 in Q1 2022, indicating a positive shift in profitability[20] Assets and Liabilities - Total assets at the end of the reporting period were ¥9,320,480,655.95, a slight decrease of 0.35% from ¥9,353,000,538.98 at the end of the previous year[3] - Total liabilities decreased to CNY 6,498,399,773.40 from CNY 6,534,818,771.77, a decline of 0.56%[16] - The total equity increased marginally to CNY 2,822,080,882.55 from CNY 2,818,181,767.21, reflecting stability in shareholder value[16] Cash Flow and Investments - Cash and cash equivalents decreased to CNY 142,992,750.49 from CNY 166,503,309.05, a decline of 14.1%[15] - The cash flow from operating activities generated a net inflow of ¥54,977,540.05, a significant improvement from a net outflow of ¥14,969,306.51 in Q1 2022[21] - Investment activities resulted in a net cash outflow of ¥20,344,101.11, contrasting with a net inflow of ¥282,865,481.43 in Q1 2022, highlighting a shift in investment strategy[23] Shareholder Information - The total number of common shareholders at the end of the reporting period is 56,764[8] - The largest shareholder, Guangzhou Kunlun Investment Co., Ltd., holds 23.09% of shares, with 152,709,621 shares pledged and 16,987,024 shares frozen[8] - The top ten shareholders collectively hold significant stakes, with the second-largest shareholder holding 4.06%[8] - The company has a total of 3,890,503 restricted shares at the end of the reporting period, with no shares released during the current period[9] Legal Matters - The company is involved in multiple legal disputes, including a contract dispute with a total execution amount of 58,912,000 RMB and another for 122,555,968 RMB[11] - The company has reached a settlement in a previous dispute but is facing enforcement actions due to unpaid amounts[11] - The company is committed to normal production operations while monitoring the progress of legal matters[12] Operating Costs and Expenses - The company reported a 41.33% increase in taxes and surcharges, attributed to higher tax obligations during the reporting period[6] - The company experienced a 305.87% increase in operating expenses, primarily due to an increase in estimated liabilities[6] - Total operating costs decreased to CNY 587,997,301.38 from CNY 713,529,042.61, representing a reduction of 17.6%[18] - Research and development expenses increased to CNY 17,941,867.46, up from CNY 14,074,755.90, reflecting a focus on innovation[18] - The company incurred a total of ¥6,828,584.34 in non-operating expenses, which is a significant increase from ¥1,682,436.25 in the previous year, indicating higher costs in this area[19] Inventory and Cash Management - Inventory increased to CNY 507,634,706.79 from CNY 467,074,930.98, an increase of 8.6%[15] - The cash and cash equivalents at the end of the period stood at ¥85,772,717.82, down from ¥328,374,768.80 at the end of Q1 2022, reflecting a decrease of approximately 73.9%[23] - Financing activities led to a net cash outflow of ¥75,181,381.45, compared to a net outflow of ¥111,112,301.34 in the same quarter last year, indicating improved cash management in financing[23] Profitability and Cost Management - Gross profit margin improved to 0.12% from a negative margin in the previous year, indicating better cost management[18] - Non-recurring gains and losses totaled ¥1,436,883.89, primarily due to government subsidies and asset disposal gains[4]